Navigating Treatment Options in Arthritis

This chapter analyzes recent research findings on treatment strategies for psoriatic arthritis and axial spondyloarthritis, comparing the effectiveness of TNF inhibitors and IL-17A inhibitors. Key insights include the lack of significant differences in primary outcomes, while emphasizing potential benefits for specific patients who switch to IL-17 inhibitors. Additionally, the chapter highlights challenges in managing giant cell arteritis and the ongoing debate surrounding the safety of oral JAK inhibitors.